OBJECTIVES: Subclinical environmental enteropathy is associated with malabsorption of fats, carbohydrates, and vitamins A, B12, and folate; however, little information is available on mineral absorption. We therefore investigated the relation between intestinal mucosal function (measured by the lactulose:mannitol permeability test and plasma citrulline concentration), and zinc (Zn) absorption, as estimated by the change in plasma Zn concentration (PZC) following short-term Zn or placebo supplementation. METHODS: We conducted a randomized, partially masked, placebo-controlled trial among 282 apparently healthy children 6 to 23 months of age in Burkina Faso. After completing baseline intestinal function tests, participants received either 5 mg Zn, as zinc sulfate, or placebo, daily for 21 days. RESULTS: At baseline, mean ± standard deviation PZC was 62.9 ± 11.9 μg/dL; median (interquartile range) urinary lactulose:mannitol (L:M) recovery ratio and plasma citrulline concentrations were 0.04 (0.03-0.07) and 11.4 (9.0-15.6) μmol/L, respectively. Change in PZC was significantly greater in the Zn-supplemented versus placebo group (15.6 ± 13.3 vs 0.02 ± 10.9 μg/dL; P < 0.0001), and was negatively associated with initial urinary L:M recovery ratio (-1.1 μg/dL per 50% increase in urinary L:M recovery ratio; P = 0.014); this latter relation did not differ between supplementation groups (P = 0.26). Baseline plasma citrulline concentration was not associated with change in PZC. CONCLUSIONS: Although altered intestinal permeability may reduce dietary Zn absorption, it likely does not undermine the efficacy of Zn supplementation, given the large increases in PZC following short-term Zn supplementation observed in this study, even among those with increased urinary L:M recovery ratios.
RCT Entities:
OBJECTIVES: Subclinical environmental enteropathy is associated with malabsorption of fats, carbohydrates, and vitamins A,B12, and folate; however, little information is available on mineral absorption. We therefore investigated the relation between intestinal mucosal function (measured by the lactulose:mannitol permeability test and plasma citrulline concentration), and zinc (Zn) absorption, as estimated by the change in plasma Zn concentration (PZC) following short-term Zn or placebo supplementation. METHODS: We conducted a randomized, partially masked, placebo-controlled trial among 282 apparently healthy children 6 to 23 months of age in Burkina Faso. After completing baseline intestinal function tests, participants received either 5 mg Zn, as zinc sulfate, or placebo, daily for 21 days. RESULTS: At baseline, mean ± standard deviation PZC was 62.9 ± 11.9 μg/dL; median (interquartile range) urinary lactulose:mannitol (L:M) recovery ratio and plasma citrulline concentrations were 0.04 (0.03-0.07) and 11.4 (9.0-15.6) μmol/L, respectively. Change in PZC was significantly greater in the Zn-supplemented versus placebo group (15.6 ± 13.3 vs 0.02 ± 10.9 μg/dL; P < 0.0001), and was negatively associated with initial urinary L:M recovery ratio (-1.1 μg/dL per 50% increase in urinary L:M recovery ratio; P = 0.014); this latter relation did not differ between supplementation groups (P = 0.26). Baseline plasma citrulline concentration was not associated with change in PZC. CONCLUSIONS: Although altered intestinal permeability may reduce dietary Zn absorption, it likely does not undermine the efficacy of Zn supplementation, given the large increases in PZC following short-term Zn supplementation observed in this study, even among those with increased urinary L:M recovery ratios.
Authors: Nicola M Lowe; Leslie R Woodhouse; Barbara Sutherland; David M Shames; Betty J Burri; Steven A Abrams; Judith R Turnlund; Malcolm J Jackson; Janet C King Journal: J Nutr Date: 2004-09 Impact factor: 4.798
Authors: Cuong D Tran; Rosa Katsikeros; Nick Manton; Nancy F Krebs; K Michael Hambidge; Ross N Butler; Geoff P Davidson Journal: Am J Clin Nutr Date: 2011-08-24 Impact factor: 7.045
Authors: Daniel J Raiten; Fayrouz A Sakr Ashour; A Catharine Ross; Simin N Meydani; Harry D Dawson; Charles B Stephensen; Bernard J Brabin; Parminder S Suchdev; Ben van Ommen Journal: J Nutr Date: 2015-04-01 Impact factor: 4.798
Authors: Kuda Mutasa; Robert Ntozini; Mduduzi N N Mbuya; Sandra Rukobo; Margaret Govha; Florence D Majo; Naume Tavengwa; Laura E Smith; Laura Caulfield; Jonathan R Swann; Rebecca J Stoltzfus; Lawrence H Moulton; Jean H Humphrey; Ethan K Gough; Andrew J Prendergast Journal: Am J Clin Nutr Date: 2021-05-08 Impact factor: 7.045
Authors: Kerri B Gosselin; Henry A Feldman; Andrew L Sonis; Lori J Bechard; Mark D Kellogg; Kathleen Gura; Robert Venick; Catherine M Gordon; Eva C Guinan; Christopher Duggan Journal: J Pediatr Gastroenterol Nutr Date: 2014-06 Impact factor: 2.839
Authors: Gwenyth O Lee; Benjamin J J McCormick; Jessica C Seidman; Margaret N Kosek; Rashidul Haque; Maribel Paredes Olortegui; Aldo A M Lima; Zulfiqar A Bhutta; Gagandeep Kang; Amidou Samie; Caroline Amour; Carl J Mason; Tahmeed Ahmed; Pablo Peñataro Yori; Domingos B Oliveira; Didar Alam; Sudhir Babji; Pascal Bessong; Estomih Mduma; Sanjaya K Shrestha; Ramya Ambikapathi; Dennis R Lang; Michael Gottlieb; Richard L Guerrant; Laura E Caulfield Journal: Am J Trop Med Hyg Date: 2017-07 Impact factor: 2.345
Authors: Eleodoro Riveras; Lorena Azocar; Tomas C Moyano; Marcia Ocares; Hector Molina; Diego Romero; Juan C Roa; Jose R Valbuena; Rodrigo A Gutiérrez; Juan F Miquel Journal: Sci Rep Date: 2020-05-04 Impact factor: 4.379
Authors: Graeme P Young; Elissa K Mortimer; Geetha L Gopalsamy; David H Alpers; Henry J Binder; Mark J Manary; Balakrishnan S Ramakrishna; Ian L Brown; Thomas G Brewer Journal: Am J Clin Nutr Date: 2014-08-13 Impact factor: 7.045
Authors: Margaret N Kosek; Estomih Mduma; Peter S Kosek; Gwenyth O Lee; Erling Svensen; William K Y Pan; Maribel Paredes Olortegui; Jay H Bream; Crystal Patil; Cesar Ramal Asayag; Graciela Meza Sanchez; Laura E Caulfield; Jean Gratz; Pablo Peñataro Yori Journal: Am J Trop Med Hyg Date: 2016-08-08 Impact factor: 2.345